Pollock Daniel Jude
Transaction: 03/18/2026
OTHER
Change
0
Price
Not reported
Filing
05/14/2026
Type
OTHER
Immuron Limited
IMRN • Biotechnology
Extraordinary move
IMRN+62.16%
vs. previous close $1.11
$1.80
▲ +0.69 (+62.16%)
Current price
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$14.64M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 65.7%Manageable debt level · 0Healthy liquidity · 7.17Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 30, 2026, 12:08 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$1.80
Change62.16%
Shares Out8.13M
Market Cap$14.64M
52W Range0.68 - 2.39
Beta0.51
P/E-4.76
P/S2.36
P/B1.62
P/FCF-5.94
EV/Sales0.31
EV/EBITDA-0.51
Price$1.80
Change62.16%
Shares Out8.13M
Market Cap$14.64M
52W Range0.68 - 2.39
Beta0.51
P/E-4.76
P/S2.36
P/B1.62
P/FCF-5.94
EV/Sales0.31
EV/EBITDA-0.51
EV/FCF-0.79
Earnings Yield-21.06%
FCF Yield-16.84%
Dividend Yield0.00%
Gross Margin64.50%
Oper. Margin-61.39%
Profit Margin-49.77%
Debt/Eq0.00
Current Ratio7.17
Quick Ratio5.90
Volume7.00K
Avg Volume178.94K
EPS Surprise-0.19
Investment DNA
How strong this company looks for long-term investors
55
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
93/100
Why this score▼
Positive revenue growth · 65.7%Manageable debt level · 0Healthy liquidity · 7.17Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 1 analyst votes · 2026-09-05
100/100
Bullish
Bullish
1
Hold
0
Bearish
0
Insider Transactions
Recent executive and insider activity
Palumbo Flavio
Transaction: 03/18/2026
OTHER
Change
0
Price
Not reported
Filing
05/14/2026
Type
OTHER
Pollock Daniel Jude
Transaction: 12/08/2025
OTHER
Change
+333,333
Price
$0.10
Filing
05/14/2026
Type
OTHER
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Pollock Daniel Jude | OTHER | 0 | Not reported | 03/18/2026 | 05/14/2026 |
| Palumbo Flavio | OTHER | 0 | Not reported | 03/18/2026 | 05/14/2026 |
| Pollock Daniel Jude | OTHER | +333,333 | $0.10 | 12/08/2025 | 05/14/2026 |
| Pollock Daniel Jude | OTHER | +1,000,000 | $0.08 | 11/24/2025 | 05/14/2026 |
| Palumbo Flavio | OTHER | +640,824 | Not reported | 10/24/2024 | 05/14/2026 |
| Brennan Paul Gerard | OTHER | +1,000,000 | $0.08 | 11/24/2025 | 05/04/2026 |
| Brennan Paul Gerard | OTHER | +666,667 | $0.18 | 11/24/2024 | 05/04/2026 |
| Savarirayan Ravi | OTHER | 0 | Not reported | 03/18/2026 | 04/29/2026 |
| Lydeamore Steven George | OTHER | 0 | Not reported | 03/18/2026 | 04/29/2026 |
| Kanellos Jerry | OTHER | 0 | Not reported | 03/18/2026 | 04/29/2026 |
| Laurita Aaron James | OTHER | 0 | Not reported | 02/09/2026 | 04/29/2026 |
| Savarirayan Ravi | OTHER | +333,333 | $0.10 | 12/08/2025 | 04/29/2026 |
| Savarirayan Ravi | OTHER | +1,000,000 | $0.08 | 11/24/2025 | 04/29/2026 |
| Joughin Jeannette Anne | OTHER | +1,000,000 | $0.08 | 11/24/2025 | 04/29/2026 |
| Joughin Jeannette Anne | OTHER | +333,333 | $0.09 | 12/09/2024 | 04/29/2026 |
| Lydeamore Steven George | OTHER | +1,778,734 | Not reported | 10/24/2024 | 04/29/2026 |
| Kanellos Jerry | OTHER | +272,134 | Not reported | 10/24/2024 | 04/29/2026 |
| Lydeamore Steven George | OTHER | +1,430,000 | $0.09 | 07/01/2022 | 04/29/2026 |